These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 512416)

  • 1. Dopamine and saralasin antagonism of renal vasoconstriction and oliguria caused by amphotericin B in dogs.
    Reiner NE; Thompson WL
    J Infect Dis; 1979 Oct; 140(4):564-75. PubMed ID: 512416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal vascular responses to infusions of 1-sarcosine-8-alanine-angiotensin II (saralasin) in man and dog [proceedings].
    Lewis PS; Wilcox CS
    J Physiol; 1978 Jul; 280():42P-43P. PubMed ID: 690897
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of angiotensin antagonists on renal vascular resistance and prostaglandin E release.
    Sugawara S; Zimmerman BG
    Clin Exp Hypertens (1978); 1978; 1(1):11-24. PubMed ID: 755643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of an angiotensin blocker (saralasin) on kidney function in dehydrated sheep.
    Yesberg NE; Henderson M; Wilson K; Law S; Cross RB
    Q J Exp Physiol; 1982 Jan; 67(1):97-103. PubMed ID: 7079453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The actions of saralasin on the renal circulation of man and dog; evidence for a sympathetic neural component to vasoconstriction.
    Wilcox CS; Lewis PS; Sever PS; Peart WS
    Eur J Clin Invest; 1981 Apr; 11(2 Suppl 1):77-83. PubMed ID: 6785099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugate effects of saralasin and indomethacin on kidney function in anesthetized dog.
    Tost H; Kövér G; Darvasi A
    Acta Physiol Hung; 1995; 83(1):63-77. PubMed ID: 7660839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular hemodynamics in rats with chronic sodium depletion. Effect of saralasin.
    Steiner RW; Tucker BJ; Blantz RC
    J Clin Invest; 1979 Aug; 64(2):503-12. PubMed ID: 457865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of nisoldipine and saralasin on angiotensin II-induced antidiuresis in anesthetized dogs.
    Kageyama M; Matsumura Y; Hayashi K; Hosokawa T; Morimoto S
    Jpn J Pharmacol; 1990 Feb; 52(2):245-53. PubMed ID: 2313933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of saralasin on renal function of the rat.
    Hofbauer KG; Bauereiss K; Zschiedrich H; Gross F
    Prog Biochem Pharmacol; 1976; 12():63-83. PubMed ID: 1019171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of [Sar1, Ala8]angiotensin II on renal vascular resistance.
    Satoh S; Zimmerman BG
    Am J Physiol; 1975 Sep; 229(3):640-5. PubMed ID: 1211457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of the competitive angiotensin II antagonist saralasin during the initial phase of glycerol-induced acute renal failure of the rat.
    Greven J; Klein H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(2):139-43. PubMed ID: 600326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
    Nichols AJ; Koster PF; Brooks DP; Ruffolo RR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):269-74. PubMed ID: 1346161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aminophylline on amphotericin B nephrotoxicity in the dog.
    Gerkens JF; Heidemann HT; Jackson EK; Branch RA
    J Pharmacol Exp Ther; 1983 Mar; 224(3):609-13. PubMed ID: 6298404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aminophylline on renal vasoconstriction produced by amphotericin B in the rat.
    Heidemann HT; Gerkens JF; Jackson EK; Branch RA
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):148-52. PubMed ID: 6646242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of sar1ala8-angiotensin II in vasopressin-treated dehydrated sheep.
    Kelly C; Wholohan T; Yesberg NE
    Q J Exp Physiol; 1983 Apr; 68(2):161-6. PubMed ID: 6856746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of saralasin acetate, a competitive inhibitor of angiotensin II, to diminish alveolar hypoxic vasoconstriction in the dog.
    Hales CA; Rouse ET; Kazemi H
    Cardiovasc Res; 1977 Nov; 11(6):541-6. PubMed ID: 603879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II inhibition on blood pressure and renal hemodynamics in pregnant rats.
    Baylis C; Collins RC
    Am J Physiol; 1986 Feb; 250(2 Pt 2):F308-14. PubMed ID: 3511733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin II and 1-Sar-8-Ala-angiotensin II on the renal function in sodium-replete and -deplete dogs [proceedings].
    Lijnen PJ; Fagard RH; Amery AK
    Arch Int Physiol Biochim; 1979 Feb; 87(1):193-4. PubMed ID: 92269
    [No Abstract]   [Full Text] [Related]  

  • 19. Vanadate-induced oliguria and vasoconstriction in the cat.
    Larsen JA; Thomsen OO
    Acta Physiol Scand; 1980 Dec; 110(4):367-74. PubMed ID: 6908997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
    Zimmerman BG; Goering JL; Raich PC
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.